Soberman D - Search Results

1

The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.

Bami S, Vagrecha A, Soberman D, Badawi M, Cannone D, Lipton JM, Cron RQ, Levy CF. Bami S, et al. Among authors: soberman d. Pediatr Blood Cancer. 2020 Nov;67(11):e28581. doi: 10.1002/pbc.28581. Epub 2020 Jul 29. Pediatr Blood Cancer. 2020. PMID: 32725881

2

Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer.

Gogineni E, Rana Z, Soberman D, Sidiqi B, D'Andrea V, Lee L, Potters L, Parashar B. Gogineni E, et al. Among authors: soberman d. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1232-1242. doi: 10.1016/j.ijrobp.2020.11.003. Epub 2020 Nov 7. Int J Radiat Oncol Biol Phys. 2021. PMID: 33171199

3

Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.

Nguyen F, Guan P, Guerrero DT, Kolla V, Naraparaju K, Perry LM, Soberman D, Pressly BB, Alferiev IS, Chorny M, Brodeur GM. Nguyen F, et al. Among authors: soberman d. Cancer Res. 2020 Oct 1;80(19):4258-4265. doi: 10.1158/0008-5472.CAN-20-1344. Epub 2020 Aug 24. Cancer Res. 2020. PMID: 32839252 Free PMC article.

4

Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models.

Alferiev IS, Guerrero DT, Soberman D, Guan P, Nguyen F, Kolla V, Fishbein I, Pressly BB, Brodeur GM, Chorny M. Alferiev IS, et al. Among authors: soberman d. Int J Mol Sci. 2022 Feb 3;23(3):1752. doi: 10.3390/ijms23031752. Int J Mol Sci. 2022. PMID: 35163672 Free PMC article.

5

Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance.

Alferiev IS, Guerrero DT, Guan P, Nguyen F, Kolla V, Soberman D, Pressly BB, Fishbein I, Brodeur GM, Chorny M. Alferiev IS, et al. Among authors: soberman d. FASEB J. 2022 Mar;36(3):e22213. doi: 10.1096/fj.202101830RR. FASEB J. 2022. PMID: 35192728 Free PMC article.

6

Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis.

Alferiev IS, Zhang K, Folchman-Wagner Z, Adamo RF, Guerrero DT, Fishbein I, Soberman D, Levy RJ, Chorny M. Alferiev IS, et al. Among authors: soberman d. Pharmaceutics. 2024 Jan 29;16(2):188. doi: 10.3390/pharmaceutics16020188. Pharmaceutics. 2024. PMID: 38399249 Free PMC article.

7

Giving more detailed information about health insurance encourages consumers to choose compromise options.

Chick SE, Hawkins SA, Soberman D. Chick SE, et al. Among authors: soberman d. Front Psychol. 2023 Nov 16;14:1257031. doi: 10.3389/fpsyg.2023.1257031. eCollection 2023. Front Psychol. 2023. PMID: 38046114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters